Dagajas, Ashira Adiya P.
HRN: 21-35-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/13/2024
07/19/2024
IV
450mg
Q6
PCAP C
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes